Brief: Elicera Updates On Preclinical CAR T-Cell Program ELC-401 For Glioblastoma
27/02/2026 08:04
Feb 27 (Reuters) - Elicera Therapeutics AB ELIC.ST: UPDATE ON PRECLINICAL CAR T-CELL PROGRAM ELC-401 FOR GLIOBLASTOMA: PRECLINICAL DEVELOPMENT CONCLUDED AND CLINICAL TRIAL PLANNING UNDERWAY Source text: ID:nWkr4w2JLd Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent